James C. said...
Does doubling time have a scale for when adjutant hormone therapy can/should be combined with SRT, or is that even anything to consider when/IF I reach the reoccurance point?
Regarding the question above, I believe the root of your question (correct me if I'm wrong) is about
whether the (possible) recurrence would be local or distant. As you know, no imaging can reveal this in early stages, so doctors typically look to the "rules of thumb." So, I am interperting your question to be "what are the rules of thumb for distant vs. local recurrence?"
Men most prone to distant metastases will have one or more of these conditions:
- Gleason scores of 8 or higher
- cancer found in their seminal vesicles and lymph nodes during surgery, or
- a rise in PSA within a year after surgery.
You, I note from your signature, had none of these conditions.
Did I interpret your question properly, or were you really asking something different?
These days I have to put lots of disclaimers and notes asking people to read closely what I wrote. Please note that I did not say that men with these conditions will have distant metastases...what I did say is that they will be prone to distant metastases. It's a medical rule of thumb. There will be exceptions, but this is what is "likely." [Sorry for the anal point of emphasis; don't want anyone flying off the handle at me for words they thought I wrote.]
Post Edited (Casey59) : 8/30/2010 8:24:27 PM (GMT-6)